j*****7
发帖数: 4348 | 1 News:
SOUTH SAN FRANCISCO, Calif., and BALTIMORE, Aug. 5 /PRNewswire-FirstCall/ --
Anesiva, Inc. (Nasdaq: ANSV - News) and Arcion Therapeutics, Inc., a
privately held company, announced today the signing of a definitive merger
agreement. The merger will result in a public company with a portfolio of
late-stage targeted pain therapeutics. The merger transaction, approved by
both companies' Boards of Directors, will combine the companies under the
name of Arcion Therapeutics, and is expected to close in the third quarter
of 2009. Upon closing of the merger, Arcion and Anesiva shareholders will
own approximately 64% and 36%, respectively, of the outstanding shares of
the combined company. Closing of the merger is contingent upon, among other
conditions, a vote of approval by Anesiva's current shareholders.
私企 (Arcion Therapeutics) 借壳上市以后一般有一拉， pipeline上面是late-stage
的药， 所以有搞头。
目标价格： 无
止损点： 无 |
|
